Tirzepatide

Description

Tirzepatide
CAS Number	2023788-19-2
Molar Mass	4813.85 g·mol−1
Chemical Formula	C225H348N48O68
IUPAC Name	20-[[(1R)-4-[2-[2-[2-[2-[2-[2-[[(5S)-5-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-2-methylpropanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-2-methylpropanoyl]amino]-4-methylpentanoyl]amino]-3-carboxypropanoyl]amino]hexanoyl]amino]-3-methylpentanoyl]amino]propanoyl]amino]-5-oxopentanoyl]amino]-6-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[2-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-6-oxohexyl]amino]-2-oxoethoxy]ethoxy]ethylamino]-2-oxoethoxy]ethoxy]ethylamino]-1-carboxy-4-oxobutyl]amino]-20-oxoicosanoic acid

Brief Introduction

Tirzepatide, a novel research compound, is prominently featured in scientific investigations exploring its potential applications. It is crucial to note that Tirzepatide is strictly intended for research purposes, and any mention of human consumption is inappropriate.

Key Characteristics

Tirzepatide has unique pharmacological properties related to metabolic regulation. Researchers are actively examining its interactions within biological systems to unravel its full spectrum of effects.

Research Applications

Tirzepatide finds application in a variety of research studies, particularly focusing on cardiovascular health, muscle growth and repair, and wound healing. Its versatile characteristics make it a subject of interest in elucidating mechanisms that may have implications for therapeutic development.

Research Benefits

Cardiovascular Health

Studies have suggested a potential link between Tirzepatide and cardiovascular health. Research examines its effects on blood pressure and lipid profiles, suggesting potential cardiovascular benefits.

Tirzepatide and Weight Loss

Tirzepatide shows promise in weight loss by influencing appetite control and promoting fullness. It may work by activating GIP and GLP-1 receptors, which help reduce food intake and increase energy expenditure. While it offers potential for obesity management, further research is needed to understand its long-term effects.

Wound Healing

Exploratory studies are underway to understand Tirzepatide’s impact on wound healing mechanisms. Initial findings suggest a possible association with accelerated wound repair processes, opening avenues for research in regenerative medicine.

Summary

In summary, Tirzepatide, as a research compound, exhibits potential benefits in cardiovascular health, muscle growth and repair, and wound healing. Researchers are actively engaged in uncovering the underlying mechanisms that may contribute to therapeutic advancements. It is essential to reiterate that Tirzepatide is exclusively intended for research purposes and should not be considered for human consumption.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer satisfaction is our top priority If you are dissatisfied with the product received, kindly contact us at 419-707-5450 or email our support team at support@bc9.co.

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Ryan DH, Deanfield JE, Jacob S. Prioritizing obesity treatment: expanding the role of cardiologists to improve cardiovascular health and outcomes. Cardiovasc Endocrinol Metab. 2023 Feb 7;12(1):e0279. doi PMID: 36777095; PMCID: PMC9911203. [Read More].
2. Wang R, Sun Q, Wu X, Zhang Y, Xing X, Lin K, Feng Y, Wang M, Wang Y, Wang R. Hypoxia as a Double-Edged Sword to Combat Obesity and Comorbidities. Cells. 2022 Nov 23;11(23):3735. doi: PMID: 36496995; PMCID: PMC9736735. [Read More].
3. Sen S, Barsun A, Romanowski K, Palmieri T, Greenhalgh D. Neuropathy May Be an Independent Risk Factor for Amputation After Lower Extremity Burn in Adults With Diabetes. Clin Diabetes. 2019;37(4):352–356. [Read More].